ARDT

Ardent Health, Inc. 2025 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: Ardent Health, Inc. (NYSE: ARDT)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Ardent is a leading provider of healthcare services operating 30 acute care hospitals and over 280 sites of care across six states (Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas). The company utilizes a joint venture (JV) model, partnering with academic medical centers and not-for-profit systems, where Ardent typically holds majority ownership and serves as the operator. As of December 31, 2025, the system employed or affiliated with over 2,000 providers and served approximately 1.2 million unique patients.

Key Financial Metrics (Year Ended Dec 31, 2025)

Note: Net income attributable to Ardent excludes $94.3 million of net income attributable to noncontrolling interests (JV partners).

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 6.0% driven by a 2.3% increase in adjusted admissions and a 3.5% increase in net patient service revenue per adjusted admission. Growth was supported by higher Medicaid supplemental payments and reimbursement rates.
• Profitability Decline: Net income attributable to Ardent decreased 35.4% year-over-year. This was primarily due to a $51.3 million increase in professional and general liability losses (specifically in New Mexico related to prior period claim developments) and a $42.6 million reduction in revenue due to a change in accounting estimate regarding accounts receivable collectability.
• Expense Increases: Total operating expenses increased 1.6% as a percentage of revenue. "Other operating expenses" rose significantly due to the aforementioned liability losses and increased provider assessments for Medicaid programs.
• Debt Refinancing: In September 2025, the company refinanced its Term Loan B Facility, reducing interest rates by 50 basis points and extending the maturity to 2032.
• Acquisitions: Completed the acquisition of 18 urgent care clinics in New Mexico and Oklahoma in January 2025 for $27.5 million.

Guidance, Outlook, and Risks

Management Commentary & Outlook: Management expects revenue from certain Medicaid supplemental payment programs to decline in 2026 due to legislative changes. The company anticipates adverse impacts from the "One Big Beautiful Bill Act" (OBBBA), which tightens Medicaid eligibility and restricts funding mechanisms. However, the company expects to offset some impacts through cost reduction initiatives and resiliency.

Key Risks and Contingencies:

• Regulatory Changes: Significant exposure to changes in Medicare and Medicaid reimbursement, particularly the OBBBA provisions reducing federal Medicaid expenditures and tightening eligibility.
• Legal Proceedings: Two active securities litigations filed in early 2026 (a class action and a derivative suit) allege incorrect accounting for accounts receivable and insurance reserves. The company intends to vigorously defend these claims but cannot estimate potential liability.
• Joint Venture Risks: A significant portion of operations (29.1% of revenue) is conducted through JVs. Conflicts with partners or changes in JV relationships could disrupt operations. Put/call agreements with certain partners could require cash settlements under specific conditions.
• Cybersecurity: Following a 2023 ransomware incident, the company continues to face heightened cyber risks. While the 2023 incident litigation was settled in 2025, future breaches remain a material risk.
• Liability Exposure: Increased social inflation and adverse claim developments in the New Mexico market have significantly impacted self-insured liability reserves.

Investor Verification Checklist

• Liability Reserves: Verify the adequacy of the $284.6 million professional and general liability accrual, specifically regarding the $51.3 million loss recognized in 2025 for New Mexico claims.
• Revenue Estimates: Review the impact of the $42.6 million revenue reduction due to the change in accounting estimate for accounts receivable collectability and the new revenue accounting system implemented in Q3 2025.
• Securities Litigation: Monitor the status of the Postiwala v. Ardent Health, Inc. and Thompson v. Sotir lawsuits filed in early 2026 regarding alleged financial misstatements.
• Medicaid Funding: Assess the specific financial impact of the OBBBA on Medicaid supplemental payments and eligibility redeterminations expected in 2026.
• Debt Covenants: Confirm compliance with the Ventas Master Lease covenants (minimum portfolio coverage ratio of 2.2x and guarantor fixed charge coverage ratio of 1.2x) and the Senior Secured Credit Facilities.